Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. INmune Bio Inc shares valued at $52,868 were purchased by Moss David J on Sep 30 ’24. At $5.29 per share, Moss David J acquired 10,000 shares. The insider’s holdings grew to 1,285,869 shares worth approximately $6.29 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Tesi Raymond Joseph purchased 15,380 shares, netting a total of over 98,048 in proceeds. Following the buying of shares at $6.38 each, the insider now holds 1,554,106 shares.
Before that, Moss David J had added 7,690 shares to its account. In a trade valued at $49,024, the Chief Financial Officer bought INmune Bio Inc shares for $6.38 each. Upon closing the transaction, the insider’s holdings increased to 7,690 shares, worth approximately $6.24 million.
As published in their initiating research note from Alliance Global Partners on October 21, 2024, INmune Bio Inc [INMB] has been a Buy and the price target has been revised to $20. Analysts at Raymond James started covering the stock with ‘”an Outperform”‘ outlook in a report released in late September. As of August 22, 2024, Scotiabank has initiated its “Sector outperform” rating for INMB. Earlier on June 01, 2023, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for INMB stock.
Analyzing INMB Stock Performance
During the last five days, there has been a surge of approximately 7.24%. Over the course of the year, INmune Bio Inc shares have dropped approximately -56.57%. Shares of the company reached a 52-week high of $14.74 on 02/14/24 and a 52-week low of $4.45 on 11/20/24. A 50-day SMA is recorded $5.35, while a 200-day SMA reached $8.41. Nevertheless, trading volume fell to 0.17 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for INmune Bio Inc (INMB)
According to the 24-hour chart, there is a support level at 4.80, which, if violated, would cause prices to drop to 4.72. In the upper region, resistance lies at 5.05. The next price resistance is at 5.22. RSI (Relative Strength Index) is 40.50 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.31, which suggests the price will decrease in the coming days. Percent R is at 75.69%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
